Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Machine Learning and Image Analysis Methods in High-content Screening for Phenotypic Drug and Gene Discovery Peter Horvath, Hungarian Academia of Sciences, speaking at Screening Europe 2015
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Detecting Single DNA Molecules with Optical Microcavities Frank Vollmer, Max Planck Institute for the Science of Light, speaking at Biodetection & Biosensors 2015
Imaging Biomarkers - Future or Reality Edwin van Beek, University of Edinburgh, speaking at Diagnostics & Biomarkers 2015.
Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Genome-Scale Protein Expression Analysis of Individual Solid Tumors Metodi Metodiev, University of Essex, speaking at Diagnostics and Biomarkers 2015.
Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test Jeff Cummings, Cancer Research UK, speaking at Diagnostics & Biomarkers 2015.